The Procter & Gamble Company (NYSE:PG) Shares Sold by Holistic Financial Partners

Holistic Financial Partners cut its stake in The Procter & Gamble Company (NYSE:PGFree Report) by 2.9% in the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 9,048 shares of the company’s stock after selling 270 shares during the period. Procter & Gamble accounts for about 0.7% of Holistic Financial Partners’ portfolio, making the stock its 23rd largest position. Holistic Financial Partners’ holdings in Procter & Gamble were worth $1,492,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds have also bought and sold shares of PG. Advantage Trust Co purchased a new stake in Procter & Gamble in the fourth quarter valued at approximately $28,000. Ruedi Wealth Management Inc. lifted its stake in Procter & Gamble by 64.7% during the 1st quarter. Ruedi Wealth Management Inc. now owns 196 shares of the company’s stock valued at $32,000 after acquiring an additional 77 shares during the period. POM Investment Strategies LLC purchased a new stake in shares of Procter & Gamble in the 2nd quarter valued at $34,000. Transcendent Capital Group LLC acquired a new stake in shares of Procter & Gamble in the fourth quarter worth $31,000. Finally, MeadowBrook Investment Advisors LLC purchased a new position in shares of Procter & Gamble during the fourth quarter worth $33,000. Institutional investors and hedge funds own 65.77% of the company’s stock.

Procter & Gamble Trading Up 0.9 %

Shares of PG opened at $171.54 on Friday. The firm’s fifty day moving average is $167.48 and its two-hundred day moving average is $164.03. The company has a quick ratio of 0.53, a current ratio of 0.73 and a debt-to-equity ratio of 0.51. The stock has a market cap of $404.86 billion, a PE ratio of 28.03, a price-to-earnings-growth ratio of 3.72 and a beta of 0.41. The Procter & Gamble Company has a 52-week low of $141.45 and a 52-week high of $171.89.

Procter & Gamble (NYSE:PGGet Free Report) last released its quarterly earnings data on Tuesday, July 30th. The company reported $1.40 EPS for the quarter, beating analysts’ consensus estimates of $1.37 by $0.03. The company had revenue of $20.53 billion during the quarter, compared to the consensus estimate of $20.69 billion. Procter & Gamble had a net margin of 17.71% and a return on equity of 33.46%. Procter & Gamble’s quarterly revenue was down .1% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.37 EPS. Research analysts forecast that The Procter & Gamble Company will post 6.97 earnings per share for the current fiscal year.

Procter & Gamble Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Thursday, August 15th. Shareholders of record on Friday, July 19th were issued a $1.0065 dividend. This represents a $4.03 annualized dividend and a yield of 2.35%. The ex-dividend date of this dividend was Friday, July 19th. Procter & Gamble’s payout ratio is currently 65.85%.

Wall Street Analyst Weigh In

Several equities research analysts have weighed in on PG shares. Evercore ISI increased their price target on Procter & Gamble from $177.00 to $183.00 and gave the stock an “outperform” rating in a research report on Thursday, July 18th. Dbs Bank downgraded Procter & Gamble from a “strong-buy” rating to a “hold” rating in a research note on Thursday, August 1st. JPMorgan Chase & Co. reduced their price target on Procter & Gamble from $181.00 to $179.00 and set an “overweight” rating for the company in a research report on Wednesday, July 31st. Deutsche Bank Aktiengesellschaft upped their price objective on shares of Procter & Gamble from $171.00 to $176.00 and gave the stock a “buy” rating in a research report on Wednesday, July 17th. Finally, StockNews.com downgraded Procter & Gamble from a “buy” rating to a “hold” rating in a research report on Thursday, August 1st. Eight investment analysts have rated the stock with a hold rating, fourteen have given a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $175.79.

View Our Latest Report on Procter & Gamble

Insiders Place Their Bets

In related news, insider Balaji Purushothaman sold 8,842 shares of the company’s stock in a transaction dated Thursday, August 1st. The shares were sold at an average price of $164.90, for a total value of $1,458,045.80. Following the completion of the sale, the insider now owns 11,537 shares of the company’s stock, valued at $1,902,451.30. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. In related news, insider Balaji Purushothaman sold 8,842 shares of the company’s stock in a transaction that occurred on Thursday, August 1st. The stock was sold at an average price of $164.90, for a total value of $1,458,045.80. Following the transaction, the insider now directly owns 11,537 shares in the company, valued at $1,902,451.30. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Susan Street Whaley sold 450 shares of the firm’s stock in a transaction on Tuesday, August 20th. The stock was sold at an average price of $169.22, for a total value of $76,149.00. Following the sale, the insider now directly owns 13,072 shares of the company’s stock, valued at approximately $2,212,043.84. The disclosure for this sale can be found here. Insiders sold 375,553 shares of company stock valued at $63,829,141 in the last three months. 0.17% of the stock is currently owned by insiders.

About Procter & Gamble

(Free Report)

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.

Featured Articles

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PGFree Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.